Chlorthalidone Treatment Group | Doxazosin Treatment Group | Total | |
---|---|---|---|
Participants with hospitalized heart failure | 245 | 296 | 541 |
Hospitalized heart failure participants reviewed | 134 | 144 | 278 |
Total reviewed heart failure participants with quantitative ejection fractions† | 46 | 59 | 105 |
By cardiac catheterization (%) | 11 (23.9) | 21 (35.6) | 32 (30.5) |
By echocardiogram (%) | 33 (71.7) | 37 (62.7) | 70 (66.7) |
Method not given (%) | 2 (4.3) | 1 (1.7) | 3 (2.9) |
Ejection fraction (%)‡ | |||
1–30% | 15 (32.6) | 27 (45.8) | 42 (40.0) |
31–40% | 14 (30.4) | 14 (23.7) | 28 (26.7) |
41–50% | 9 (19.6) | 7 (11.9) | 16 (15.2) |
51–60% | 3 (6.5) | 10 (16.9) | 13 (12.4) |
>60% | 5 (10.9) | 1 (1.7) | 6 (5.7) |